|1.||Aurora, Sheena K: 7 articles (09/2015 - 06/2010)|
|2.||Turkel, Catherine C: 6 articles (09/2015 - 06/2010)|
|3.||DeGryse, Ronald E: 5 articles (09/2015 - 06/2010)|
|4.||Lipton, Richard B: 5 articles (09/2015 - 06/2010)|
|5.||Silberstein, Stephen D: 5 articles (09/2015 - 06/2010)|
|6.||Dodick, David W: 5 articles (09/2015 - 06/2010)|
|7.||Diener, Hans-Christoph: 4 articles (09/2015 - 06/2010)|
|8.||Turkel, C C: 4 articles (01/2014 - 07/2010)|
|9.||Aurora, S K: 4 articles (01/2014 - 07/2010)|
|10.||Dodick, D W: 4 articles (01/2014 - 07/2010)|
|1.||Migraine Disorders (Migraine)
03/10/2014 - "PREEMPT studies demonstrate that OnabotA is a safe an effective prophylactic treatment for chronic migraine. "
07/01/2013 - "Efficacy data and utility values were taken from the pooled Phase III REsearch Evaluating Migraine Prophylaxis Therapy (PREEMPT) clinical trials program (n = 1384). "
07/01/2010 - "The Phase III REsearch Evaluating Migraine Prophylaxis Therapy 1 (PREEMPT 1) is a phase 3 study, with a 24-week, double-blind, parallel-group, placebo-controlled phase followed by a 32-week, open-label phase. "
06/01/2010 - "The 2 multicenter, pivotal trials in the PREEMPT: Phase 3 REsearch Evaluating Migraine Prophylaxis Therapy clinical program each included a 24-week randomized, double-blind phase followed by a 32-week open-label phase (ClinicalTrials.gov identifiers NCT00156910, NCT00168428). "
01/01/2015 - "All patients were injected using the PREEMPT (Phase 3 REsearch Evaluating Migraine Prophylaxis Therapy) protocol for migraine. "
01/01/2014 - "Our results support findings of PREEMPT study in a large cohort of patients, we believe, is representative of the patients seen in an average tertiary headache centre. "
04/16/2012 - "Pooled findings from two large phase III studies of virtually identical design (PREEMPT [Phase III REsearch Evaluating Migraine Prophylaxis Therapy] 1 and 2) showed that treatment with up to five cycles of onaBoNTA (155-195 units/cycle) at 12-week intervals was effective in reducing headache symptoms, decreasing headache-related disability, and improving health-related quality of life (HR-QOL) in patients with chronic migraine, approximately two-thirds of whom were overusing acute headache medications at baseline. "
03/30/2012 - "A pooled analysis of the data from two programmes of Phase 3 Research Evaluating Migraine Prophylaxis Therapy (PREEMPT 1 and 2) with BoNT-A in chronic migraine demonstrated significant benefit of BoNT-A over placebo with regard to the numbers of headache days and migraine episodes. "
09/01/2015 - "To help inform decisions about treating non-responders, we examined the probability of treatment cycle 1 non-responders responding in cycle 2, and cycle 1 and 2 non-responders responding in cycle 3. Pooled PREEMPT data (two studies: a 24-week, 2-cycle, double-blind, randomised (1:1), placebo-controlled, parallel-group phase, followed by a 32-week, 3-cycle, open-label phase) evaluated onabotulinumtoxinA (155-195 U) for prophylaxis of headaches in persons with CM (≥15 days/month with headache ≥4 h/day). "
01/01/2014 - "PREEMPT (two phase III studies: 24-week double-blind, placebo-controlled [DBPC], parallel-group phase, followed by 32-week open-label [OL] phase) evaluated the efficacy and safety of onabotulinumtoxinA in CM (≥15 days/month with headache lasting ≥4 h a day). "
10/01/2001 - "While the means by which these tumors preempt the p53 tumor suppressor response remains to be established, this study provides further evidence that irreversible inactivation of this pathway is not a prerequisite for tumor development in vivo."
01/01/2013 - "This tumor exemplifies malignancies which require surgical resection to preempt worse outcomes. "
10/01/2009 - "However, accurate and timely diagnosis may preempt the misdiagnosis of cancer and decrease the number of unnecessary pancreatic resections."
01/01/1988 - "This series demonstrates that FNA biopsy with ultrasound guidance can provide an accurate diagnosis of malignancy and may preempt a lengthy workup in the search for a primary tumor."
09/01/1990 - "It is concluded that cytologic examination of colonic brushings is a highly accurate and reliable technique for the detection of malignant neoplasms of the colon and can preempt the use of biopsy forceps."
01/01/2015 - "The goal of the PREEMPT study is to test the 'Trialist' mobile health smartphone app, which has been developed to make n-of-1 trials easier to accomplish, and to provide patients and clinicians with tools for individualizing treatments for chronic pain. "
01/01/2015 - "The PREEMPT study - evaluating smartphone-assisted n-of-1 trials in patients with chronic pain: study protocol for a randomized controlled trial."
10/01/2010 - "The Phase III REsearch Evaluating Migraine Prophylaxis Therapy (PREEMPT) injection paradigm uses both fixed and follow-the-pain sites, with additional specific follow-the-pain sites considered depending on individual symptoms. "
05/01/1996 - "Sufentanil does not preempt pain after abdominal hysterectomy."
|2.||Botulinum Toxins (Botulinum Toxin)
|3.||Type A Botulinum Toxins (Botulinum A Toxin)
|7.||Proteins (Proteins, Gene)
|8.||Parathyroid Hormone (Parathormone)
|2.||Surgical Instruments (Clip)
|3.||Artificial Respiration (Mechanical Ventilation)